SCHEMBL10407035

SCHEMBL10407035

C=CCOC(=O)C(C)(C)ON1C(=O)c2ccccc2C1=O

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.53
▸ RHOA P61586 1/20 0.44
▸ CYP3A4 P08684 1/20 0.42
▸ POLB P06746 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ CASP3 P42574 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ PKM P14618 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14587496 0.83 CA12 (0.44) ALDH1A1NPSR1CYP3A4TSHRCYP1A2
SCHEMBL17662056 0.80 ALDH1A1 (0.56) ALDH1A1NPSR1RHOACYP3A4POLB
SCHEMBL10542563 0.78 ALDH1A1 (0.41) ALDH1A1POLBCYP1A2CYP2C9MAPT
SCHEMBL9143592 0.78 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP2C9MAPTGAA
SCHEMBL17662067 0.78 ALDH1A1 (0.53) ALDH1A1NPSR1RHOACYP3A4POLB
SCHEMBL10548122 0.77 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2C9MAPTGAA
SCHEMBL10851006 0.77 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2C9MAPTGAA
SCHEMBL30660870 0.77 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2C9MAPTGAA
SCHEMBL9425523 0.75 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP1A2CYP2C9MAPT
SCHEMBL29565442 0.75 ALDH1A1 (0.46) ALDH1A1HSD17B10CYP1A2CYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4966900-A FOR MICROBISM THERAPY, BACTERIAL INFECTIONS SANKEI PHARMACEUTICAL COMPANY LTD. (JP) 1990-10-30 — — US disclosed
EP-0286145-A2 3-Heterocyclylthiomethyl cephalosporins SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1988-10-12 — — EP disclosed
EP-0254495-A2 Beta-Lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1988-01-27 — — EP disclosed
Send feedback